• Clip
• Bones & joints >> Rheumatoid Arthritis >> Disease duration 0-5 years >> Linda - Interview 60 >> Linda talks about how she felt before she started on Simponi and how successful it has been in helping controlled RA. Her consultant has written to th

Linda was diagnosed with rheumatoid arthritis (RA) in April 2010 and she is currently taking part in a clinical trial for Golimumab. This therapy, has significantly improved Linda’s quality of life. She no longer has flares ups that had previously affected her working life. She is awaiting a decision from her PCT as to whether they will pay for her to continue having this treatment.

• Bones & joints >> Rheumatoid Arthritis >> Disease duration 11-15 years >> Interview 33 >> Describes her involvement in a clinical trial.

Juvenile chronic arthritis diagnosed 1990. Initially NSAIDs, then methotrexate but nausea & then oral steroids from age 15. Finger tendon repair & hip replacement (01) Currently Anti-TNF Humira injected 2/month, indometacin, co-codamol & Lansoprazole.

• Bones & joints >> Rheumatoid Arthritis >> Disease duration 26 years plus >> Interview 16 >> Took part in a clinical trial of cannabis for inflammatory pain.

Diagnosed 1977 after shoulder pains. Diclofenac retard 100mg/day, Methotrexate 15mg/week & 5mg/day folic acid. Partial wrist & 2 finger joints replaced, thumb tendon repairs, 6 toe joint operations, ankle fusion & a back operation (not due to RA).

• Bones & joints >> Rheumatoid Arthritis >> Disease duration 16-20 years >> Pat - Interview 59 >> Pat felt well when on Simponi but test’s results showed that it hadn’t made any difference to her RA. Pat withdrew from the trial.

Pat was diagnosed with rheumatoid arthritis aged 25 but it took almost three years and a progressive deterioration of her symptoms for her to get an appropriate treatment. Her disease has remained active and to date she has had ten operations and four implants. Pat participated in a clinical trial for a newer drug called Golimumab (Simponi) but the therapy failed to improve or control her rheumatoid arthritis. She is due to start another biological therapy; Rituximab.

• Bones & joints >> Rheumatoid Arthritis >> Disease duration 0-5 years >> Linda - Interview 60 >> Linda encourages other patients to volunteer to take part in clinical trials.

Linda was diagnosed with rheumatoid arthritis (RA) in April 2010 and she is currently taking part in a clinical trial for Golimumab. This therapy, has significantly improved Linda’s quality of life. She no longer has flares ups that had previously affected her working life. She is awaiting a decision from her PCT as to whether they will pay for her to continue having this treatment.

• Bones & joints >> Rheumatoid Arthritis >> Disease duration 16-20 years >> Pearl - Interview 62 >> Pearl explains how her participation in a clinical trial for Simponi (golimumab) came about.

Pearl was diagnosed with rheumatoid arthritis (RA) in 1991, aged forty and was put on methotrexate. Eighteen months ago and initially as part of a clinical trial, she started to take a newer anti-TNF therapy; Simponi. Her current treatment also includes methrotrexate, but in a smaller dosage.

• Bones & joints >> Rheumatoid Arthritis >> Disease duration 16-20 years >> Pearl - Interview 62 >> After the clinical trial finished, Pearl started receiving regular deliveries of her anti-TNF medication at home. She does not recall PCT funding ever

Pearl was diagnosed with rheumatoid arthritis (RA) in 1991, aged forty and was put on methotrexate. Eighteen months ago and initially as part of a clinical trial, she started to take a newer anti-TNF therapy; Simponi. Her current treatment also includes methrotrexate, but in a smaller dosage.